Benjamin loves to spend his free time playing outdoors on his family’s farm – fishing, catching crawdads, and chasing around the goats and chickens. Learn more about Benjamin and his experience navigating hypochondroplasia through the eyes of his mother Lora, who is advocating for greater acceptance of people living with genetic skeletal conditions. https://bit.ly/4eLjFhw
BioMarin Pharmaceutical Inc.
生物技术研究
San Rafael，CA 173,340 位关注者
We transform lives through genetic discovery.
关于我们
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions that it seeks to treat, helping to better the lives of those struggling with rare genetic disease. BioMarin discoveries have led to eight first or best-in-class commercial treatments and a pipeline of multiple product candidates applying the same science-driven, patient-forward approach to broader group of genetic disorders. The more innovative solutions developed, the more lives BioMarin can impact. Recruitment Fraud Alert Notice Please be aware of fraud or scams from individuals, organizations and/or internet sites claiming to represent BioMarin in recruitment activities. We have an established recruitment process which is required for all posted positions by BioMarin prior to issuing an offer of employment. This BioMarin process requires formal interviews conducted live with personnel representing BioMarin and never requires payments or fees from job applicants. BioMarin does not conduct interviews via texting tools such as RingCentral. In the event you receive a suspicious email message about recruiting on behalf of BioMarin, unless it’s from a BioMarin authorized recruiting partner, do not provide any personal information or pay any fees. Qualified and interested candidates should apply to current openings directly through this BioMarin website. BioMarin accepts no responsibility for any costs or charges incurred as a result of fraudulent activity. If you have lost money or provided your personal identifying information, please contact your bank and report the matter to the FBI via www.ic3.gov. We would also suggest you notify your local police department and monitor your credit. We appreciate your interest in BioMarin & encourage you to visit https://careers.biomarin.com/career-areas to review job opportunities.
- 网站
-
https://www.BioMarin.com
BioMarin Pharmaceutical Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 1,001-5,000 人
- 总部
- San Rafael，CA
- 类型
- 上市公司
- 创立
- 1997
- 领域
- Transform lives through genetic discovery.
地点
BioMarin Pharmaceutical Inc.员工
动态
-
Kathryn Lowell, our GVP, Global Government Affairs, has been recognized as one of the 2024 Most Influential Women in Bay Area Business by the San Francisco Business Times. Kathryn was honored both for her acumen as an industry-leading legislative strategist and?her commitment to the community. She?serves?on national, state and county-level boards?and dedicates time outside of work to volunteer in the local?Marin community.?Congratulations Kathryn – we join you in celebrating this award! Learn more about Kathryn here: https://bit.ly/3zX6kDC
-
-
Our LatinX employee resource group (ERG) coordinated a volunteer opportunity for employees to help support Latinx college students, along with local high school and elementary students, in recognition of Hispanic Heritage Month. Employees came together at our site in Novato, California to assemble school supply kits and care packages for the Chicanx and Latinx Engineers and Scientists Society at the University of California, Davis. The kits also went to students at Antioch High School via our community partner Biotech Partners Inc., San Rafael High School, and Lynnwood Elementary in Novato. We’re proud of our LatinX ERG’s longstanding commitment to supporting students, particularly those who have demonstrated interest in STEM fields.
-
-
Meet Jiayi (Bryan) Yan, a RARE Scholars award recipient and third-year student at the University of Minnesota College of Pharmacy who is living with achondroplasia. He reflects on how his lived experiences have motivated him to share his story and raise awareness for others living with skeletal conditions. Read more about Jiayi's story and the rest of the 2024-25 RARE Scholars here: https://bit.ly/3MX5TMi #BioMarinRAREscholars #achondroplasia
-
Stories like Kainen's inspire us to continue working to help improve the experiences of people living with #Duchenne muscular dystrophy. As our team joins neuromuscular scientists and clinicians at the World Muscle Society Annual Congress in Prague, hear from Kainen’s family to learn more about their journey to diagnosis and hopes for the future: https://bit.ly/4dSw1Un #WMS2024
-
We’re looking forward to attending the first-ever Little Legs Big Heart Skeletal Dysplasia Conference in November. The inaugural event will bring together individuals, families and healthcare professionals to explore medical advancements, share knowledge and encourage community-building. Learn more about the conference, including how to register: https://bit.ly/4dABChm. #littlelegsbigheartfoundation The Little Legs Big Heart Foundation
-
-
An oligonucleotide is a molecule consisting of a short sequence of nucleotides, the building blocks of DNA and RNA. These molecules can alter the expression of genes. Oligonucleotides are one of several modalities our scientists are studying to develop breakthrough medicines for people with serious medical conditions.
-
“The first day we brought her home, we knew we were going to treat her just like any other kid… Our hope for her future is that she conquers the world and does whatever she wants.” With her family’s support and encouragement, KK brings excitement, passion and fearlessness to everything she does, whether it’s soccer, swimming, cheerleading or horseback riding. As we recognize the start of #DwarfismAwarenessMonth, we’re excited to amplify the voices and experiences of people like KK who are living with #achondroplasia and other genetic skeletal conditions. Learn more about her story: https://bit.ly/4e5Nrwz
-
We're pleased to join our partners at CAMP4 Therapeutics in announcing a new research collaboration aimed at advancing novel therapeutics that increase protein levels by targeting regulatory RNA (regRNA) sequences, which are key elements controlling gene expression. Learn more: https://bit.ly/3ZLa5q0
-
“Our lives could have been different without that early diagnosis… I’m hopeful that newborn screening continues to expand to cover more conditions and the goals of newborn screening will be fully realized.” Denise Queally still vividly remembers the moment in 2001 when she learned her newborn daughter, Caroline, had screened positive for phenylketonuria (PKU), a rare, genetic metabolic condition. That phone call and the interactions that followed set her family on a path to help Caroline effectively manage her condition and connect with a close-knit community that inspired Denise to become an advocate for people living with PKU and other metabolic conditions. Learn more about Denise’s story, her work and what newborn screening has meant to her family: https://bit.ly/4eJGUrB #NewbornScreening #NewbornScreeningAwarenessMonth
-